158 related articles for article (PubMed ID: 28459467)
1. Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
Dai L; Lin Z; Qiao J; Chen Y; Flemington EK; Qin Z
Oncogene; 2017 Aug; 36(35):5068-5074. PubMed ID: 28459467
[TBL] [Abstract][Full Text] [Related]
2. Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma.
Dai L; Trillo-Tinoco J; Cao Y; Bonstaff K; Doyle L; Del Valle L; Whitby D; Parsons C; Reiss K; Zabaleta J; Qin Z
Blood; 2015 Dec; 126(26):2821-31. PubMed ID: 26531163
[TBL] [Abstract][Full Text] [Related]
3. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M
Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777
[TBL] [Abstract][Full Text] [Related]
4. Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
Caro-Vegas C; Bailey A; Bigi R; Damania B; Dittmer DP
mBio; 2019 Feb; 10(1):. PubMed ID: 30782662
[TBL] [Abstract][Full Text] [Related]
5. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S
Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells.
He M; Tan B; Vasan K; Yuan H; Cheng F; Ramos da Silva S; Lu C; Gao SJ
J Pathol; 2017 Jul; 242(3):309-321. PubMed ID: 28393364
[TBL] [Abstract][Full Text] [Related]
8. HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway.
Kariya R; Taura M; Suzu S; Kai H; Katano H; Okada S
Cancer Lett; 2014 Jan; 342(1):52-9. PubMed ID: 24012878
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma.
Lam BQ; Dai L; Li L; Qiao J; Lin Z; Qin Z
Oncotarget; 2017 Mar; 8(11):18373-18380. PubMed ID: 28407694
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.
Li J; Zheng LM; King I; Doyle TW; Chen SH
Curr Med Chem; 2001 Feb; 8(2):121-33. PubMed ID: 11172670
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.
Ueno M; Kariya R; Sittithumcharee G; Okada S
Phytomedicine; 2021 May; 85():153545. PubMed ID: 33799222
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
[TBL] [Abstract][Full Text] [Related]
14. Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo.
Towata T; Komizu Y; Suzu S; Matsumoto Y; Ueoka R; Okada S
Leuk Res; 2010 Jul; 34(7):906-11. PubMed ID: 20074798
[TBL] [Abstract][Full Text] [Related]
15. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma.
Chen J; Goyal N; Dai L; Lin Z; Del Valle L; Zabaleta J; Liu J; Post SR; Foroozesh M; Qin Z
Blood; 2020 Nov; 136(19):2175-2187. PubMed ID: 32518949
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
Biochem Pharmacol; 1994 Jul; 48(2):335-44. PubMed ID: 8053929
[TBL] [Abstract][Full Text] [Related]
17. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
Qin Z; Dai L; Trillo-Tinoco J; Senkal C; Wang W; Reske T; Bonstaff K; Del Valle L; Rodriguez P; Flemington E; Voelkel-Johnson C; Smith CD; Ogretmen B; Parsons C
Mol Cancer Ther; 2014 Jan; 13(1):154-64. PubMed ID: 24140934
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.
Sarosiek KA; Cavallin LE; Bhatt S; Toomey NL; Natkunam Y; Blasini W; Gentles AJ; Ramos JC; Mesri EA; Lossos IS
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13069-74. PubMed ID: 20615981
[TBL] [Abstract][Full Text] [Related]
19. Diethyldithiocarbamate induces apoptosis in HHV-8-infected primary effusion lymphoma cells via inhibition of the NF-κB pathway.
Matsuno T; Kariya R; Yano S; Morino-Koga S; Taura M; Suico MA; Shimauchi Y; Matsuyama S; Okamoto Y; Shuto T; Kai H; Okada S
Int J Oncol; 2012 Apr; 40(4):1071-8. PubMed ID: 22200846
[TBL] [Abstract][Full Text] [Related]
20. Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.
Wong JP; Stuhlmiller TJ; Giffin LC; Lin C; Bigi R; Zhao J; Zhang W; Bravo Cruz AG; Park SI; Earp HS; Dittmer DP; Frye SV; Wang X; Johnson GL; Damania B
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16541-16550. PubMed ID: 31346082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
